Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

6.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.3K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

407
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
407

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Centered Approach to Surgical Prevention of Ovarian Cancer: A Nonrandomized Clinical Trial.

JAMA network open·2026
Same author

Correction: PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma.

Cancer research communications·2025
Same author

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

Cell·2025
Same author

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Nature communications·2025
Same author

Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Cancer research communications·2025

Related Experiment Video

Updated: Apr 30, 2026

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

11.4K

Blocking and randomization to improve molecular biomarker discovery.

Li-Xuan Qin1, Qin Zhou2, Faina Bogomolniy3

  • 1Authors' Affiliations: Departments of Epidemiology and Biostatistics and qinl@mskcc.org.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|May 3, 2014
PubMed
Summary

Randomization and blocking improve molecular biomarker discovery by controlling nonbiologic effects. Implementing these methods in genomics studies enhances accuracy and reduces false positives, leading to more reliable results.

More Related Videos

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.8K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K

Related Experiment Videos

Last Updated: Apr 30, 2026

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

11.4K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.8K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K

Area of Science:

  • Genomics
  • Molecular Biology
  • Biostatistics

Background:

  • Nonbiologic effects can negatively impact molecular biomarker discovery.
  • Randomization and blocking are statistical methods to mitigate these effects.
  • Their practical application in genomics research remains limited.

Purpose of the Study:

  • To demonstrate the logistic feasibility and scientific benefits of using randomization and blocking in molecular biomarker discovery.
  • To compare the impact of blocked randomization versus no blocking/randomization on differential gene expression analysis.

Main Methods:

  • A microRNA study of endometrial and ovarian tumors (n=96 each) using a blocked randomization design.
  • Profiling the same tumors a second time without blocking or randomization for comparison.
  • Empirical assessment of differential gene expression and simulations via virtual rehybridizations.

Main Results:

  • Randomized dataset showed moderate differential expression (10%) between tumor types.
  • Nonrandomized dataset exhibited significant nonbiologic effects, with 55% of markers showing differential expression.
  • Simulations indicated blocking improved true-positive rates (0.95 to 0.97) and reduced false-positive rates (0.02 to 0.002) under balanced conditions.

Conclusions:

  • Randomization and blocking are crucial for accurate molecular biomarker discovery.
  • These methods effectively control nonbiologic variations, enhancing the reliability of genomic studies.
  • Widespread adoption of randomization and blocking is recommended to maximize the benefits of genomics technologies.